To Top

Archives for: May 11th, 2022

NORD Applauds Congressional Efforts to Restore Intent of the Orphan Drug Act

Written by Rohan Narayanan on May 11, 2022

Washington, DC — The National Organization for Rare Disorders (NORD) applauds efforts of Congressional leaders to protect the Orphan Drug Act (ODA) and ensure proper incentives are in place to continue to foster robust rare disease drug development. Last week, leaders of the House Energy and Commerce Committee… Read More